Cohen Klingenstein’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
RRAM
JIC
BCWM
AAM
DIA
SFA
WCM
HPCM
MCM
ET
Cohen Klingenstein's LH Position: Q2 2026 in Review
Cohen Klingenstein reduced its Labcorp (LH) stake by 5.9% in Q2 2026, selling an estimated $384K and leaving 23,250 shares worth $6.51M. The position accounts for 0.19% of the portfolio, ranked #60.
Cohen Klingenstein first reported a position in LH in Q1 2019 and has held it in 30 quarters since. The position peaked at $12.3M in Q2 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Cohen Klingenstein held 23,250 shares of Labcorp worth $6.51M as of Q2 2026.
- Cohen Klingenstein sold 1,460 Labcorp shares in Q2 2026, an estimated $384K.
- Labcorp made up 0.19% of Cohen Klingenstein's portfolio in Q2 2026, its #60 holding.
- Cohen Klingenstein first reported a position in Labcorp in Q1 2019 and has held it in 30 quarters since.
- Cohen Klingenstein's Labcorp position peaked at $12.3M in Q2 2021.
- 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.